NCT03678818View on ClinicalTrials.gov

Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 25, 2018

Primary Completion Date

April 20, 2019

Study Completion Date

April 30, 2019

Conditions
Infertility
Interventions
OTHER

Medium Supplemented with Latrunculin A

A medium with in-house supplementation of Latrunculin A to decrease oocyte degeneration after ICSI and improve the survival rate

Trial Locations (2)

Unknown

Banon Assiut, Asyut

IbnSina IVF Center, Sohag

All Listed Sponsors
lead

Ibn Sina Hospital

OTHER_GOV

NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) | Biotech Hunter | Biotech Hunter